NCT00091117View on ClinicalTrials.gov

Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2013

Conditions
Hepatic ComplicationsMalignant Neoplasm
Interventions
DRUG

bortezomib

Given IV

OTHER

pharmacological study

Correlative studies

Trial Locations (3)

48202

Wayne State University, Detroit

91010

City of Hope Medical Center, Duarte

21287-8936

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00091117 - Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction | Biotech Hunter | Biotech Hunter